ImmuCell Publishes Update to Financial Calendar

By Public Technologies
  • ImmuCell expects unaudited results for the quarter ended Sept. 30, 2026, on Nov. 12, 2026, following the market close.
  • Its Form 10-Q filing is also expected Nov. 12, 2026, following the market close.
  • A conference call and webcast to review results are scheduled for Nov. 13, 2026, at 9 a.m. ET.
  • A conference call replay will be available through Nov. 20, 2026.
  • No changes are anticipated to preliminary quarterly sales results disclosed Oct. 12, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImmuCell Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611061605PRIMZONEFULLFEED9872564) on November 06, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.